Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Rotashield, a vaccine protective against rotavirus infection was withdrawn from the U.S. market because of an apparent excess risk of intussusception. The recent introduction of a new vaccine, RotaTeq, has inevitably led to concerns about an increased incidence of this complication in children receiving this vaccine, as well.

RotaTeq Safety